SubEx
Semaglutide·Manage weight·finding 03 of 19
↓
★★★Well replicated — this finding’s sources average out to meta-analyses, systematic reviews or high-powered trials.

Metabolic & weight · decreases · well replicated

Four years in, weight was still 10.2% below where it started

In 17,604 people with heart disease, weight fell for 65 weeks and then held: at week 208 it sat 10.2% below baseline, against 1.5% on placebo.

What the study found

The longest randomised weight data runs four years and shows 10.2%

Weight kept falling for 65 weeks and then simply stayed down. In 17,604 people with heart disease and no diabetes, mean weight at week 208 was 10.2% below baseline against 1.5% on placebo, with waists 7.7cm smaller against 1.3cm.

The caveat · Older group than the obesity trials

This was a prespecified secondary analysis, not what the trial was built to answer. The 10.2% is lower than the obesity trials' figures because this group was older, already had heart disease and started at a lower body mass index, not because the effect wears off. People came off the drug more often than off placebo.